ArticleNature communications2025

PARP inhibitor radiosensitization enhances anti-PD-L1 immunotherapy through stabilizing chemokine mRNA in small cell lung cancer.

Xiaozhuo Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.